What is Senti Biosciences Inc?
, a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 5.38M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.